Malaria
512 results
1 - 100
Malaria- Infectious Agent
- Transmission
- Epidemiology
- Clinical Presentation
- Diagnosis
- Treatment
- Prevention
- Mosquito Avoidance Measures
- Chemoprophylaxis
- Box 4-5. Malaria considerations for the long-term traveler (travel >6 months)
- Changing Medications as a Result of Side Effects During Prophylaxis
- Obtaining Medications Overseas
- Medications used for Prophylaxis
- Travel to Areas with Limited Malaria Transmission
- Travel to Areas with Chloroquine-Sensitive Malaria
- Travel to Areas with Chloroquine-Resistant Malaria
- Travel to Areas with Mefloquine-Resistant Malaria
- Prophylaxis for Infants, Children, and Adolescents
- Prophylaxis During Pregnancy and Breastfeeding
- Choosing a Drug to Prevent Malaria
- Blood Donation After Travel to Malarious Areas
- Bibliography
- Authors
- Yellow Fever Vaccine & Malaria Prophylaxis Information, by Country
- Yellow Fever and Malaria World Map
COVID-19 News from the CDC- Ethiopia
- Kenya
- Namibia
- Peru
- United States
- Brazil
- Colombia
- Panama
- Venezuela
- Botswana
- Mexico
- Nicaragua
- Thailand
- Bolivia
- Burma (Myanmar)
- India
- South Africa
- Traveling Safely with Infants & Children
- International Adoption
- Haiti
- Nepal
- Greece
- Visiting Friends & Relatives: VFR Travel
- Suriname
- Brazil
- Ecuador, Including the GaláPagos Islands
- India
- Peru: Cusco, Machu Picchu & Other Regions
- East Africa: Safaris
- Western Sahara
- Guyana
- Comoros
- Guatemala
- Tajikistan
- Tanzania: Kilimanjaro
- Cape Verde
- Djibouti
- Angola
- El Salvador
- Rwanda
- South Africa
- Benin
- Cameroon
- Ghana
- Guinea
- Liberia
- Mali
- Niger
- Nigeria
- Senegal
- Togo
- Vanuatu
- Haiti
- China